Show simple item record

FieldValueLanguage
dc.contributor.authorSavard, J
dc.date.accessioned2016-09-07
dc.date.available2016-09-07
dc.date.issued2013-01-01
dc.identifier.citationSavard, J. (2013). "Epidemiology, quality control and consumer access in the medical marketplace: the changing landscape of human genetic technology regulation in Australia." Journal of law and medicine 20(3): 595-603.en_AU
dc.identifier.urihttp://hdl.handle.net/2123/15622
dc.description.abstractAdvances in genetics, genetic therapeutics and the application of genetic technologies to many aspects of human life have challenged the capacity of regulatory authorities and legislative processes the world over. In Australia, developments in the “new genetics” prompted the government to initiate a major inquiry into the protection of human genetic information, resulting in the production and publication of Report 96, titled “Essentially Yours: The Protection of Human Genetic Information in Australia” in 2003. This article examines the recommendations set out in this report and how they have provided Australia with a framework to deal with the advances in human genetic technologies, using the examples of direct-to-consumer personal genome testing and whole-genome sequencing.en_AU
dc.language.isoenen_AU
dc.publisherLawbook Co. / Thomson Reutersen_AU
dc.subjectgeneticsen_AU
dc.subjecthuman genetic informationen_AU
dc.subjectdirect-to-consumer personal genome testingen_AU
dc.subjectwhole-genome sequencingen_AU
dc.subjectAustraliaen_AU
dc.titleEpidemiology, quality control and consumer access in the medical marketplace: the changing landscape of human genetic technology regulation in Australiaen_AU
dc.typeArticleen_AU
dc.type.pubtypePost-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.